Showing results 7 to 9 of 9
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II Proceeding/Conference:Journal of Clinical Oncology | 2012 | 164 | ||
2019 | 93 | |||
2021 | 2 |